Back to search

Switzerland· 55560006

Zyvoxid 2 mg/ml, Infusionslösung

A linezolid product containing linezolidum, registered in Switzerland by Pfizer AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 19 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC J01XX08

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedZyvoxid 2 mg/ml, InfusionslösungATCJ01XX08REGISTER NO.55560006PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Linezolid is registered in 19 of 19 countries.

Countries holding a registration under ATC J01XX08 (linezolid), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 11 of them publish a price we can compare per daily dose

Linezolid · ATC J01XX08

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of linezolid costs, country by country.

Normalised to the WHO defined daily dose (1.2 g), so markets compare like for like.

  • Switzerland: $125.76 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Linezolid · price per daily dose (1.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$125.76
  • IT Italy$109.29
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
linezolidum
Manufacturer
Pfizer AG
Country
Switzerland (CH)
ATC code
J01XX08
ATC class
Linezolid
Defined daily dose
1.2 g, O
Swissmedic category
A
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680555600066
    10 Freeflex 300 ml
    CHF 606.7

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

393 interactions on record for linezolid.

Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Linezolid · interactions on record

393 records

  • 69 severe
  • 196 moderate
  • 116 info

Most severe, free to view

  • IsomethepteneA03AX10severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe

12 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Linezolid in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All linezolid products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Ilenozyd, Linezolid 1a Pharma
  • Belgium · Linezolid Fresenius Kabi, Linezolid Sandoz
  • Bulgaria · Linezolid Kabi, Линезолид Крка
  • Cyprus · Apel, Linezid
  • Czechia · Linezolid Accord, Linezolid Demo
  • Germany · Linezolid 1 A Pharma, Linezolid Accord
  • Denmark · Linezolid "sandoz", Linezolid Accord
  • Estonia · Apel, Linezolid Accord
  • Spain · Apel, Linezolid Accordpharma
  • Finland · Linezolid Accord, Linezolid Krka
  • France · Linezolide Accord, Linezolide Arrow
  • United Kingdom (Northern Ireland) · Linezolid, Linezolid Accord Healthcare
  • Greece · Antizolid, Linesol
  • Croatia · Linezolid Kabi, Linezolid Krka
  • Hungary · Anozilad, Linesan
  • Ireland · Linezolid, Linezolid Accord Healthcare Ireland
  • Iceland · Zyvoxid
  • Italy · Linezolid Aurobindo, Linezolid Aurobindo Italia
  • Lithuania · Disenil, Linezolid Accord
  • Luxembourg · Linezolid Dr. Eberth, Linezolid Fresenius Kabi
  • Latvia · Apel, Linezolid Accord
  • Malta · Apel, Zyvox
  • Netherlands · Dilizolen, Linezolid Accord
  • Norway · Linezolid Accord, Linezolid Fresenius Kabi
  • Poland · Dilizolen, Linezolid Eugia
  • Portugal · Linezolida Accord, Linezolida Accordpharma
  • Romania · Linezolid, Linezolid Aurobindo
  • Sweden · Linezolid Accord, Linezolid Glenmark
  • Slovenia · Linezolid Accord, Linezolid Kabi
  • Slovakia · Apel, Linezolid Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e1e2ba3c-5981-4d2e-a1c2-53ddd194c3f0
GET /v1/drugs/e1e2ba3c-5981-4d2e-a1c2-53ddd194c3f0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "linezolidum 2 mg",
  "valid_from": "2012-01-01",
  "limitations": "[{\"description\":\"Behandlung nosokomialer Pneumonien,<br>\\nkomplizierter Haut- und Weichteilinfektionen,<br>\\nVancomycin-resistenter Enterococcus faecium-Infektionen einschliesslich Bakteriämie.\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2007-01-01\"}]",
  "galenic_form": "Inf Lös 2 mg/ml",
  "therapeutic_area": null,
  "sl_inclusion_date": "2012-01-01",
  "self_retention_pct": 10
}

See everything about linezolid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.